NLRP3 and neoplasm: This conflicts with the findings of Zheng and Liu, who discovered higher expression of NLRP3, ASC, caspase‐1, and IL‐1B in lymph node‐positive PDAC cases; however, it is worth noting that their study included only stage I–II tumors and segmentation of tumor cells from stroma was not performed [16].